About Michael Redman
Form D filings for GreenJay Therapeutics from 2023 to 2024 list Michael Redman as director.
Michael Redman first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Michael Redman in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Michael Redman works with at each company, as listed on that company's latest Form D.
GreenJay Therapeutics, Inc. · Form D, Apr 22, 2024